Kite Pharma (KITE) Shares Tick Higher Pre-Market
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Kite Pharma (NASDAQ: KITE) gained premarket following an appearance by the company's CEO on CNBC.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Skyline Medical (SKLN) Appoints New CEO, Board Member
- Sears Holdings (SHLD) Director Mnuchin Resigns Amid Trump Nod
- SoTHERLY Hotels (SOHO) Approves $10M Stock Buyback Plan